MRK [NYSE]
Merck & Co., Inc.
IndexDJIA S&P500 P/E13.94 EPS (ttm)6.56 Insider Own0.10% Shs Outstand2.53B Perf Week2.78%
Market Cap226.23B Forward P/E12.21 EPS next Y7.49 Insider Trans0.00% Shs Float2.53B Perf Month1.95%
Income16.64B PEG1.26 EPS next Q1.75 Inst Own75.20% Short Float0.66% Perf Quarter-0.76%
Sales57.17B P/S3.96 EPS this Y173.50% Inst Trans0.43% Short Ratio1.59 Perf Half Y18.36%
Book/sh17.09 P/B5.35 EPS next Y1.56% ROA16.10% Target Price100.68 Perf Year17.50%
Cash/sh4.09 P/C22.34 EPS next 5Y11.07% ROE41.90% 52W Range70.89 - 95.72 Perf YTD19.26%
Dividend2.76 P/FCF29.80 EPS past 5Y28.20% ROI15.50% 52W High-4.51% Beta0.33
Dividend %3.02% Quick Ratio1.10 Sales past 5Y4.10% Gross Margin70.80% 52W Low28.93% ATR1.78
Employees68000 Current Ratio1.40 Sales Q/Q28.00% Oper. Margin33.00% RSI (14)56.85 Volatility1.55% 2.00%
OptionableYes Debt/Eq0.73 EPS Q/Q225.10% Profit Margin29.00% Rel Volume0.00 Prev Close91.40
ShortableYes LT Debt/Eq0.66 EarningsJul 28 BMO Payout41.50% Avg Volume10.55M Price91.40
Recom2.20 SMA202.05% SMA501.31% SMA2008.94% Volume0 Change0.00%
Jul-06-22Upgrade Daiwa Securities Neutral → Buy $89 → $102
Jun-06-22Resumed SVB Leerink Outperform $102
Apr-06-22Resumed Morgan Stanley Equal-Weight $80
Dec-17-21Initiated Goldman Buy $93
Dec-16-21Initiated Daiwa Securities Neutral $70
Dec-13-21Downgrade UBS Buy → Neutral $98 → $76
Dec-09-21Initiated Wells Fargo Overweight $90
Dec-07-21Downgrade Guggenheim Buy → Neutral
Nov-29-21Downgrade Citigroup Buy → Neutral $105 → $85
Nov-19-21Initiated BMO Capital Markets Market Perform $91
Nov-01-21Upgrade Argus Hold → Buy $110
Sep-07-21Downgrade Morgan Stanley Overweight → Equal-Weight $85
Jul-27-21Resumed Truist Buy $92
May-20-21Downgrade Argus Buy → Hold
Apr-07-21Resumed RBC Capital Mkts Sector Perform $79
Nov-10-20Resumed Bernstein Outperform $95
Sep-29-20Initiated Berenberg Hold $88
Aug-03-20Upgrade Goldman Neutral → Buy $91 → $105
Jun-12-20Downgrade Wolfe Research Outperform → Peer Perform
Feb-27-20Initiated Barclays Overweight $93
Aug-18-22 02:49PM  
09:55AM  
09:50AM  
08:51AM  
04:40AM  
Aug-17-22 03:11PM  
01:11PM  
08:47AM  
08:06AM  
Aug-16-22 03:36PM  
02:20PM  
12:36PM  
12:05PM  
11:53AM  
09:48AM  
07:01AM  
07:00AM  
06:45AM  
06:01AM  
02:04AM  
Aug-15-22 02:19PM  
10:40AM  
09:34AM  
09:16AM  
09:00AM  
07:11AM  
Aug-14-22 11:09AM  
Aug-12-22 03:34PM  
11:21AM  
10:05AM  
06:50AM  
Aug-11-22 03:01PM  
02:10PM  
01:13PM  
08:45AM  
Aug-10-22 02:56PM  
11:20AM  
10:55AM  
10:05AM  
09:38AM  
09:13AM  
07:43AM  
07:00AM  
Aug-09-22 04:46PM  
01:54PM  
01:21PM  
12:08PM  
11:18AM  
09:40AM  
09:10AM  
Aug-08-22 04:20PM  
12:29PM  
10:45AM  
09:17AM  
08:03AM  
Aug-07-22 09:37AM  
06:00AM  
04:10AM  
Aug-05-22 03:43PM  
12:01PM  
09:00AM  
07:29AM  
Aug-04-22 03:01PM  
01:37PM  
01:32PM  
08:40AM  
06:45AM  
Aug-03-22 07:38PM  
12:30PM  
12:17PM  
10:27AM  
09:54AM  
08:53AM  
08:46AM  
06:45AM  
06:40AM  
05:52AM  
Aug-02-22 12:14PM  
10:11AM  
09:00AM  
08:25AM  
Aug-01-22 12:45PM  
12:00PM  
10:08AM  
08:10AM  
Jul-31-22 07:00AM  
Jul-29-22 03:28PM  
11:30AM  
11:18AM  
06:40AM  
Jul-28-22 06:00PM  
04:25PM  
01:07PM  
01:05PM  
12:46PM  
12:14PM  
10:46AM  
09:45AM  
09:30AM  
09:25AM  
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Garay ArpaSVP Human Health Global Mktg.May 04Option Exercise87.1090779,0002,368May 05 05:24 PM
Oosthuizen Johannes JacobusSVP, U.S. MarketMay 04Option Exercise87.1090779,00014,961May 05 05:27 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise87.1094982,65841,429May 05 05:19 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 04Option Exercise87.1088577,08415,775May 05 05:07 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 04Option Exercise87.1081370,8123,943May 05 05:04 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 03Option Exercise87.6545239,6183,285May 04 05:58 PM
Litchfield CarolineEVP & CFOMay 03Option Exercise87.6577367,75327,799May 04 05:54 PM
Li Dean YExecutive VP & President, MRLMay 03Option Exercise87.6577367,75316,839May 04 05:50 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 03Option Exercise87.6542737,4279,410May 04 05:44 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 03Option Exercise87.6590279,06040,789May 04 05:37 PM
Oosthuizen Johannes JacobusSVP, U.S. MarketMay 03Option Exercise87.6577367,75314,435May 04 05:30 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 03Option Exercise87.6577367,75315,271May 04 04:53 PM
Garay ArpaSVP Human Health Global Mktg.May 03Option Exercise87.6577367,7531,682May 04 04:45 PM
Garay ArpaSVP Human Health Global Mktg.May 03Option Exercise87.6577367,7531,682May 04 04:44 PM
LeCointe-Cephas LisaSVP Chief Ethics & Com OfficerMay 01Option Exercise88.6964056,7623,053May 03 04:25 PM
Williams David MichaelEVP,Chief Info&Digital OfficerMay 01Option Exercise88.6957751,1749,181May 03 04:19 PM
Li Dean YExecutive VP & President, MRLMay 01Option Exercise88.691,06194,10016,589May 03 04:21 PM
Litchfield CarolineEVP & CFOMay 01Option Exercise88.6986676,80627,453May 03 04:22 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 01Option Exercise88.6992882,30440,205May 03 04:17 PM
Oosthuizen Johannes JacobusSVP, U.S. MarketMay 01Option Exercise88.6986676,80614,089May 03 04:16 PM
Klobuchar Michael AEVP - Chief Strategy OfficerMay 01Option Exercise88.6986676,80614,925May 03 04:13 PM
Garay ArpaSVP Human Health Global Mktg.May 01Option Exercise88.6986676,8061,156May 03 04:11 PM
Williams David MichaelEVP,Chief Info&Digital OfficerFeb 10Option Exercise76.531,20291,9897,421Feb 14 11:13 AM
FRAZIER KENNETH CExecutive ChairNov 09Option Exercise0.00663,88101,250,676Nov 10 04:06 PM
FRAZIER KENNETH CExecutive ChairNov 09Sale82.26663,88154,611,362586,795Nov 10 04:06 PM
Litchfield CarolineEVP & CFONov 04Option Exercise0.0022,683042,449Nov 05 04:22 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 04Option Exercise0.0029,7820146,712Nov 05 04:24 PM
Litchfield CarolineEVP & CFONov 04Sale91.0018,3351,668,50324,114Nov 05 04:22 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthNov 04Sale90.4029,7822,692,299116,930Nov 05 04:24 PM
Karachun Rita ASr. VP Fince-Global ControllerNov 03Option Exercise0.0025,000060,799Nov 04 04:19 PM
Karachun Rita ASr. VP Fince-Global ControllerNov 03Sale88.4525,0002,211,21535,799Nov 04 04:19 PM
Clyburn FrankEVP & Pres ? Human HealthNov 01Option Exercise0.0039,7620136,857Nov 02 06:16 PM
Gerberding Julie L.EVP, Chief Patient OfficerNov 01Option Exercise0.0096,2700135,432Nov 03 04:11 PM
Gerberding Julie L.EVP, Chief Patient OfficerNov 01Sale87.9196,2708,462,68239,162Nov 03 04:11 PM
Clyburn FrankEVP & Pres ? Human HealthNov 01Sale87.8739,7623,493,87997,095Nov 02 06:16 PM
Clyburn FrankEVP & Pres ? Human HealthOct 30Option Exercise88.052,358207,62298,257Nov 02 06:16 PM
MIZELL STEVENEVP, Chief HR OfficerOct 30Option Exercise88.054,715415,15627,896Nov 02 06:11 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthOct 29Option Exercise0.00135,4050252,335Nov 02 06:12 PM
Chattopadhyay SanatExe V-P & Pres. MMDOct 29Option Exercise0.0024,6190117,764Nov 02 06:14 PM
Chattopadhyay SanatExe V-P & Pres. MMDOct 29Sale87.3224,6192,149,73193,145Nov 02 06:14 PM
DeLuca Richard R.EVP&Pres, Merck Animal HeallthOct 29Sale87.56135,40511,856,265116,930Nov 02 06:12 PM